Jeff Goater
InvestorPartner at The Column Group
Boston, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
About
Jeff Goater leverages a career from research scientist to Evercore investment banker to biotech CEO, bringing deep technical, company-building expertise and a hands-on style as executive chair or interim CEO.
Invests in
BiotechHealthtech
Experience
- Judo BioBoard Membercurrent2026 β present
- Judo BioExecutive Chair2022 β 2026
- Tortugas NeuroscienceBoard Membercurrent2025 β present
- NILO TherapeuticsBoard Membercurrent2024 β present
- Kenai TherapeuticsBoard Membercurrent2024 β present
- The Column GroupPartnercurrent2024 β presentBoston, Massachusetts, United States
- The Column GroupVenture Partner2021 β 2023
- Remix TherapeuticsBoard Membercurrent2023 β present
- AviadoBioChaircurrent2023 β present
- KallyopeBoard Membercurrent2022 β present
- Topo TherapeuticsBoard Member2024 β 2026
- Atavistik BioBoard Member2021 β 2026Cambridge, Massachusetts, United States
- Atavistik BioInterim CEO2022 β 2023
- Ribon TherapeuticsBoard Member2021 β 2024Cambridge, MA
- Surface Oncology Inc.Board Member2018 β 2023Cambridge, Massachusetts, United States
- Surface Oncology Inc.CEO2018 β 2021Cambridge, MA
- Surface Oncology Inc.CBO2017 β 2018Cambridge, MA
- LogicBio TherapeuticsBoard Member2020 β 2022Lexington, Massachusetts, United States
- VaccinexBoard Member2013 β 2022
- Voyager Therapeutics, Inc.CFO2016Cambridge, MA
Education
- University of Rochester - Simon Business SchoolMBA
- University of Rochester School of Medicine and DentistryMS, Microbiology / Immunology
- University of Rochester School of Medicine and DentistryMS, Pathology
- University of RochesterBA, Biology
Skills & more
Corporate Finance8Start-ups9Corporate Development15Valuation6Mergers & Acquisitions27Due Diligence12Business Development23Licensing2Venture Capital7Investment Banking4M&A experience2Emerging Markets1
+4 more
Private EquityIPOFinancial ModelingBiotechnologyFrom Jeff's professional profile.
Same school
Also attended University of Rochester - Simon Business School20
Camila VieiraPartner, Head of Brazil at QED InvestorsAndy WeymannVenture Partner, Frontiers in Health & Bio Investments at Verve VenturesDeepali NangiaPartner at SpeedinvestWei JiangFounder & Managing Partner at CatchLight Capital PartnersTim JonesPartner at ICISurya ManthaManaging Partner at Capria Ventures
+ 14 more
Also attended University of Rochester School of Medicine and Dentistry4
Also attended University of Rochester56
Hal PazInvestor at Khosla VenturesCamila VieiraPartner, Head of Brazil at QED InvestorsWilliam SheahanSenior Vice President and Chief Innovation Officer at Flare Capital PartnersArtur BergmanFounder, Fastly at Amplify PartnersNicole VitulloInvestor at Arboretum VenturesSunil DhaliwalGeneral Partner at Amplify Partners
+ 50 more
Shared employers
Also worked at Tortugas Neuroscience2
Also worked at NILO Therapeutics1
Also worked at Kallyope4
Deals Β· 2
RYNE Biotechnology Inc.Board seat
via The Column Group Β· filed Mar 2024 Β· $81.8M raise
Ribon TherapeuticsBoard seat
via The Column Group Β· filed Dec 2022 Β· $25M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
David Goeddel
Managing Partner at The Column Group
David V. Goeddel, PhD
Partner Emeritus at The Column Group
Helen Kim
Partner at The Column Group
Hui Tian
Partner at The Column Group
Network2
Investors connected to Jeff in public investor directories β a warm-intro map.






























